PFE
Pfizer Inc
NYSE: PFE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$26.70
+1.68% today
Updated 2026-04-30
Market cap
$149.38B
P/E ratio
19.31
P/S ratio
2.39x
EPS (TTM)
$1.36
Dividend yield
6.50%
52W range
$21 – $29
Volume
38.0M
Pfizer Inc (PFE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
12.40%
Operating margin
23.90%
ROE
8.89%
ROA
5.68%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $48.37B | $11.02B | 78.27% | 31.20% | 22.79% |
| 2007 | $48.43B | $8.21B | 75.79% | 28.75% | 16.95% |
| 2008 | $48.30B | $8.02B | 79.22% | 34.42% | 16.61% |
| 2009 | $50.01B | $8.63B | 76.82% | 32.01% | 17.27% |
| 2010 | $67.06B | $8.27B | 69.11% | 26.44% | 12.33% |
| 2011 | $61.03B | $8.71B | 71.88% | 30.12% | 14.26% |
| 2012 | $54.66B | $9.79B | 73.21% | 33.00% | 17.91% |
| 2013 | $51.58B | $11.65B | 72.95% | 32.74% | 22.58% |
| 2014 | $49.60B | $9.08B | 73.17% | 28.28% | 18.30% |
| 2015 | $48.85B | $6.97B | 73.07% | 27.22% | 14.26% |
| 2016 | $52.82B | $7.21B | 69.80% | 27.02% | 13.66% |
| 2017 | $52.55B | $21.30B | 69.97% | 27.39% | 40.55% |
| 2018 | $53.65B | $11.15B | 70.16% | 28.50% | 20.79% |
| 2019 | $41.17B | $16.27B | 69.34% | 18.24% | 39.52% |
| 2020 | $41.65B | $9.16B | 71.74% | 21.81% | 21.99% |
| 2021 | $81.29B | $22.15B | 57.67% | 25.58% | 27.25% |
| 2022 | $100.33B | $31.36B | 61.89% | 37.43% | 31.26% |
| 2023 | $59.55B | $2.13B | 50.95% | 8.89% | 3.58% |
| 2024 | $63.63B | $8.02B | 65.77% | 25.91% | 12.60% |
| 2025 | $62.58B | $7.77B | 70.33% | 24.67% | 12.42% |